Pages that link to "Q40037564"
Jump to navigation
Jump to search
The following pages link to HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region (Q40037564):
Displaying 10 items.
- Trafficking through the Rev/RRE pathway is essential for efficient inhibition of human immunodeficiency virus type 1 by an antisense RNA derived from the envelope gene (Q30439325) (← links)
- In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy (Q34221633) (← links)
- HIV-1 RT-dependent DNAzyme expression inhibits HIV-1 replication without the emergence of escape viruses (Q34513742) (← links)
- Stem cell-based anti-HIV gene therapy (Q34769333) (← links)
- Antiviral RNAi: translating science towards therapeutic success (Q37914065) (← links)
- Use of N-methylpiperazine for the preparation of piperazine-based unsymmetrical bis-ureas as anti-HIV agents. (Q39995992) (← links)
- Efficacy Analysis of Combinatorial siRNAs against HIV Derived from One Double Hairpin RNA Precursor (Q40044425) (← links)
- Adaptation of HIV-1 to rhTrim5α-mediated restriction in vitro (Q40429354) (← links)
- Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide. (Q41191267) (← links)
- CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile? (Q52430698) (← links)